Full Length Research Paper
References
| Armentia A, Mendez J, Gomez A, Sanchis E, Fernandez A, De la Fuente R, Sanchez P (1993). Urticaria by <I>Blastocystis hominis</I>. Succe ssful treatment with paromomycin. Allergologia et Immunopathologia 21:149-151. | ||||
| Bancroft JD, Stevens A (1975). Histopathological Stains and their Diagnostic Uses. Churchill Livingstone, Edunberg, London and New York pp. 25-46. | ||||
|
Basuldo JA, Cordoba MA, de Luca MM, Ciarmela ML, Pezzani BC, Grenovero MS, Minvielle MC (2007). Intestinal parasitoses and environmental factors in a rural population of Argentina, 2002-2003. Rev. Inst. Med. Trop Sao Paulo 49:251-255. Crossref |
||||
| Blagg W, Schloegel EL, Mansour NS, Khalaf GJ (1955). A new concentration technic for the demonstration of protozoa and Helminth eggs in feces. Am. J. Trop. Med. Hyg. 4:23-28. | ||||
| Boeva-Bangyozova V, Panayotova M, Chakarova B (2008). Blastocystosis: Pathogenesis, clinical course, diagnostics and treatment. Trakia J. Sci. 6:94-97. | ||||
|
Calzada F, Yepez-Mulia L, Tapia-Contreras A (2007). Effect of Mexican medicinal plant used to treat trichomoniasis on Trichomonas vaginalis trophozoites. J. Ethnopharmacol. 113(2):248-51. Crossref |
||||
|
Campbell RC (1989). Statistics for Biologists. 3rd Edn., Cambridge University Press,. Cambridge, UK p 446. Crossref |
||||
| Chen TL, Chan CC, Chen HP, Fung CP, Lin CP, Chan WL, Liu CY (2003). Clinical Characteristics and endoscopic findings associated with <I>Blastocystis hominis</I> in healthy adults. Am. J. Trop. Med. Hyg. 69:213-216. | ||||
|
Dinleyici EC, Eren M, Dogan N, Reyhanioglu S, Yargic ZA, Vandenplas Y (2011). Clinical efficacy of <I>Saccharomyces boulardii</I> or metronidazole in symptomatic children with <I>Blastocystis hominis</I> infection. Parasitol. Res. 108:541-545. Crossref |
||||
| Eida AM, Eida MM (2008). Identification of <I>Blastocystis hominis</I> in patients with irritable bowel syndrome using microscopy and culture compared to PCR. Parasitol. United J. 1:87-92. | ||||
| El-Shewy KA, El-Hamshary EM, Abaza SM, Eida AM (2002). Prevalence and clinical significance of Blastocystis hominis among school children in Ismailia city. Egypt. J. Med. Sci. 23:31-40. | ||||
| El-Wakil SS (2007). Evaluation of the in vitro effect of Nigella sativa aqueous extract on Blastocystis hominis isolates. J. Egypt Soc. Parasitol. 37:801-813. | ||||
| El-Gayar EK, Soliman RH (2011). In vitro and in vivo effects of Quillaja on Blastocystis hominis isolates. PUJ 4:101-108. | ||||
| El-Shazly AM, Awad SE, Sultan DM, Sadek GS, Khalil HH, Morsy TA (2006). Intestinal parasites in <I>Dakahlia governorate</I>, with different techniques in diagnosing protozoa. J. Egypt. Soc. Parasitol. 36:1023-1034. | ||||
| Garavelli PL (1991). The therapy of blastocystosis. J. Chemother. 3:245-246. | ||||
|
Grimaud JA, Druget M, Peyrol S, Chevalier D (1980). Collageimmuno-typing in human liver: Light and electron microscope study. J. Histochem. Cytol. 28:1145-1151. Crossref |
||||
|
Hassan SI, Moussa HME, Fahmy ZH, Mohamed AM (2010). In Vitro the effect of medium-chain saturated fatty acid (dodecanoic acid) on Blastocytsis spp. Int. J. Infect. Dis. 14:584. Crossref |
||||
|
Hien TT, White NJ (1993). Qinghaosu. Lancet 341:603-608. Crossref |
||||
| Hussien A, Virmami OP, Popli SP (2008). Dictionary of Indian Medicinal Plants. CIAP, Lucknow, India p 2384. | ||||
| Jones WR (1946). The experimental infection of rats with Entamoeba histolytica; with a method for evaluating the anti-amoebic properties of new compounds. Ann. Trop. Med. Parasitol. 40:130-140. | ||||
| Kaya S, Cetin E, Aridogan BC, Arikan S, Demirci M (2007). Pathogenicity of <I>Blastocystis hominis</I>, a clinical reevaluation. Turkiye Parazitol. Derg 31:184-187. | ||||
|
Lemee V, Zaharia I, Nevez G, Rabodonirina M, Brasseur P, Ballet JJ, Favennec L (2000). Metronidazole and albendazole susceptibility of 11 clinical isolates of <I>Giardia duodenalis</I> from France. J. Antimicrob. Chemother. 46:819-821. Crossref |
||||
| Mahmod SS, Guirgus N, Helmy A, Sabry H (2006). Effect of a novel antimalarial drug on different pathological and parasitological parameters in experimental intestinal giardiasis. New Egypt. J. Med. 35:38-43. | ||||
| Melvin DM, Brooke MM (1974). Laboratory Procedures for the Diagnosis of Intestinal Parasites. 2nd Edn., U.S. Department of Health, Education and Welfare, Washington, DC., USA p 199. | ||||
|
Moghaddam DD, Ghadirian E, Azami M (2005). <I>Blastocystis hominis</I> and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole. Parasitol. Res. 96:273-275. Crossref |
||||
|
Nigro LL, Larocca L, Massarelli I, Patamia I, Minniti S, Palermo F, Cacopardo B (2003). A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J. Travel Med. 10:128-130. Crossref |
||||
| Ozcakir OS, Gureser S, Erguven YA, Yilniaz R, Topaloglu R, Hascelik G (2007). Characteristics of Blastocystis hominis infection in a Turkish university hospital. Turkiye Parazitol. Derg. 31:277-282. | ||||
| Rayan HZ, Ismail OA, El Gayar EK (2007). Prevalence and clinical features of Dientamoeba fragilis infections in patients suspected to have intestinal parasitic infection. J. Egypt. Soc. Parasitol. 37:599-608. | ||||
| Rohner K, Demuth D (1994). Adverse effects of veterinary drugs. Schweiz Arch. Tierheilkd. 136:309-312. | ||||
|
Rossignol JF, Kabil SM, Said M, Samir H, Younis AM (2005). Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin. Gastroenterol. Hepatol. 3:987-991. Crossref |
||||
| Sanmi AA (2012). Oxidative stress in biochemical, seminological and histological alterations due to acute administration of intramuscular artemether in mice. Researcher 4:9-17. | ||||
|
Sawangjaroena N, Sawangjaroen B (2005). The effect of extracts from anti-diarrheic Thai Medicinal plants on the in vitro growth of the intestinal protozoa parasite: Blastocystis hominis. J. Ethnopharmacol. 98:67-72. Crossref |
||||
|
Stark D, van Hal S, Marriott D, Ellis J, Harkness J (2007). Irritable bowel syndrome: A review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int. Parasitol. 37:11-20. Crossref |
||||
|
Stensvold CR, Smith HV, Nagel R, Olsen KE, Traub RJ (2010). Eradication of Blastocystis carriage with antimicrobials: Reality or delusion? J. Clin. Gastroenterol. 44:85-90. Crossref |
||||
|
Tan KSW (2004). <I>Blastocystis</I> in humans and animals: New insights using modern methodologies. Vet. Parasitol. 126:121-144. Crossref |
||||
|
Tan KSW (2008). New Insights on classification, identification and clinical relevance of Blastocystis spp. Clin. Microbiol. Rev. 21:639-665. Crossref |
||||
|
Tang W (1992). Chinese Drugs of Plant Origin. Springer Verlag. Berlin. pp. 160-174. Crossref |
||||
| Tasova Y, Sahin B, Koltas S, Paydas S (2000). Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Medica Okayama 54:133-136. | ||||
| Ustun S, Turgay N (2006). Blastocystis hominis and bowel diseases. Turkiye Parazitol. Derg. 30:72-76. | ||||
|
Valsecchi R, Leghissa P, Greco V (2004). Cutaneous lesions in <I>Blastocystis hominis</I> infection. Acta Derm. Venereol. 84:322-323. Crossref |
||||
| Zhang HW, Li W, Yan QY, He LJ, Su YP (2006). Impact of Blastocystis hominis infection on ultrastructure of intestinal mucosa in mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, 24:187-191. | ||||
|
Zierdt CH (1988). Blastocystis hominis, a long-misunderstood intestinal parasite. Parasitol. Today 4:15-17. Crossref |
||||
| Zierdt CH (1991). Blastocystis hominis past and future. Clin. Microbiol. Rev. 4:61-79. | ||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
